• Worst Pills, Best Pills



• Health Letter



• Health Links



• Activist Courses



• Take Action!



• Drug Safety



• Healthcare Delivery



• Medical Devices



• Food Safety



• Occupational Health

Testimony Before the FDA Advisory Committees on Possible Switch of Orlistat (XENICAL) to OTC Status (HRG Publication #1760)

Testimony of Sidney M. Wolfe MD and Elizabeth Barbehenn, Ph.D.,
Public Citizen’s Health Research Group

Before the FDA Non-Prescription and Endocrine and Metabolic Drug Advisory Committees

Hearing on Possible Switch of
Orlistat to OTC Status

January 23, 2006

Click HERE to view the presentation slides in pdf format

more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.